Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-30 00:45:15 - browse：8

FDA's Peter Marks talks with STAT's Adam Feuerstein — Peter Marks, the FDA's top regulator of gene therapies (right), speaks with STAT's Adam Feuerstein in San Francisco. Sarah Gonzalez/Peopletography for STAT

SAN FRANCISCO — Peter Marks, the Food and Drug Administration’s top regulator of gene therapies, seems very comfortable with granting some form of full approval to Elevidys, the Sarepta Therapeutics gene therapy for Duchenne muscular dystrophy, based on his comments to me on Monday night during our “fireside chat” at a STAT event.

To be clear, Marks declined to comment specifically about the ongoing FDA review of Elevidys. I tried. However, Marks described a “hypothetical case” in the context of my Sarepta questions that clearly suggested the failure of an Elevidys confirmatory study in October didn’t bother him all that much.

“Hypothetically, if you had a product that used an aggregate scale and all of the components of that aggregate scale looked pretty good, or nearly all of them look pretty good, but the aggregate, for various reasons, didn’t come out perfectly. We approved products based on that,” Marks told me.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： How to make Best Hospitals ratings actually useful for patients

WSS

Winners, losers from Medicare’s list of drugs subject to price talks

Study finds new variant for Parkinson’s in African populations

Medicare has a new plan to address drug shortages

How to make AI work for medicine

Feds fine Medicare Advantage plans for overcharging members

Sanders adds drug shortage policies to pandemic preparedness bill

focus

Wikipedia

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Sports medicine is finally prioritizing gender equality

In science, is the line between industry and academia shifting?

United colonoscopy coverage change 'may cost lives,' doctors say

Psilocybin's anti

New air purifier tech could be key to improving indoor air quality

Cosmetics set for new safety regulation. Why the industry is on board

United colonoscopy coverage change 'may cost lives,' doctors say

What AAP's gender

Wikipedia

2024 GOP presidential candidates spar over abortion in debate

Winners, losers from Medicare’s list of drugs subject to price talks

Rescued Australian man who was adrift 3 months in Pacific with dog 'grateful' to be alive

At Orexo, a ‘turning point’ for everything but digital health

Sanders adds drug shortage policies to pandemic preparedness bill

Psilocybin's anti

leisure time

leisure time

entertainment

hotspot